Zobrazeno 1 - 10
of 22
pro vyhledávání: '"S. A. Provan"'
Autor:
S. A. Provan, S. Rollefstad, E. Ikdahl, A. Mathiessen, I. J. Berg, I. Eeg, I. B. Wilkinson, C. M. McEniery, T. K. Kvien, H. B. Hammer, N. Østerås, I. K. Haugen, A. G. Semb
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-9 (2019)
Abstract Background The objective of this study was to explore the associations between ultrasonographic and radiographic joint scores and levels of arterial CVD risk markers in patients with osteoarthritis (OA). Secondly, to compare the levels of ar
Externí odkaz:
https://doaj.org/article/a2e09d2b88644a6bb198aa0372c3f6a0
Autor:
B. Glintborg, D. DI Giuseppe, J. K. Wallman, D. Nordström, B. Gudbjornsson, M. L. Hetland, J. Askling, G. Gröndal, T. Sokka-Isler, S. Aarrestad Provan, U. Lindström
Publikováno v:
Annals of the Rheumatic Diseases. 81:766-767
BackgroundThe treatment landscape in psoriatic arthritis (PsA) is changing, including newer biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) with different modes of action becoming available. However, the most effect
Autor:
I. Egeland Christensen, I. Jyssum, A. T. Tveter, J. Sexton, T. T. Tran, S. Mjaaland, G. B. Kro, T. K. Kvien, D. Worren, J. Jahnsen, L. A. Munthe, E. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, K. K. Jørgensen, S. W. Syversen, G. L. Goll, S. Aarrestad Provan
Publikováno v:
Annals of the Rheumatic Diseases. 81:116-117
BackgroundLimited data is available regarding long-term effectiveness of SARS-CoV-2 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy. Whether the persistence of vaccine-induced humoral immunity agai
Autor:
B. Delcoigne, T. I. Kopp, E. Arkema, K. Hellgren, S. Aarrestad Provan, H. Relas, K. Aaltonen, N. Trokovic, B. Gudbjornsson, G. Gröndal, E. Kristianslund, L. Dreyer, J. Askling
Publikováno v:
Annals of the Rheumatic Diseases. 81:41-41
BackgroundThough rare, studies have reported increased risk of neurological events including demyelinating disease of CNS (DML), multiple sclerosis (MS), and inflammatory neuropathy (INP) in patients with inflammatory joint disease treated with tumor
Autor:
R. Cordtz, J. Askling, B. Delcoigne, K. Ekström Smedby, E. Baecklund, C. Ballegaard, P. Isomäki, K. Aaltonen, B. Gudbjornsson, T. Love, S. A. Provan, B. Michelsen, J. Sexton, L. Dreyer, K. Hellgren
Publikováno v:
Annals of the Rheumatic Diseases. 81:169.2-170
BackgroundSeveral autoimmune inflammatory diseases, including rheumatoid arthritis (RA), are associated with increased risk of malignant lymphomas. There is also a longstanding concern of lymphoma development with tumour necrosis factor inhibitor (TN
Publikováno v:
Annals of the Rheumatic Diseases. 81:549.2-550
BackgroundRheumatoid arthritis (RA) patients have a reduced life expectancy, with cardiovascular disease (CVD) being the most frequent cause of death. The mechanisms behind the increased CVD morbidity and mortality in RA are not fully understood. Sys
Publikováno v:
Annals of the Rheumatic Diseases. 81:129.1-130
BackgroundPatients with fibromyalgia (FM) suffer from high symptom burden and few available treatments. EULAR evidence-based recommendations for the management of FM state that optimal management should focus on prompt diagnosis, patient education an
Autor:
I. Jyssum, A. T. Tveter, J. Sexton, I. E. Christensen, T. T. Tran, S. Mjaaland, D. J. Warren, T. K. Kvien, K. H. Bjørlykke, G. B. Kro, J. Jahnsen, L. A. Munthe, E. A. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, S. Aarrestad Provan, K. K. Jørgensen, G. L. Goll, S. W. Syversen
Publikováno v:
Annals of the Rheumatic Diseases. 81:127.1-128
BackgroundPatients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy have an inadequate serologic response following two-dose SARS-CoV-2 vaccination, and a standard vaccination strategy of three doses for this patient gr
Autor:
Eirik Kristianslund, Lotta Ljung, S. Aarrestad Provan, Bjorn Gudbjornsson, D. Di Giuseppe, Heikki Relas, G. B. Reynisdóttir, Brigitte Michelsen, M.L. Hetland, T. Jonmundsson, Johan Askling, T.K. Kvien, Kalle Aaltonen, Dan Nordström, B. Glintborg
Publikováno v:
Annals of the Rheumatic Diseases. 80:133-134
Background:Interstitial lung disease (ILD) is an established extra-articular manifestation of rheumatoid arthritis (RA). Few studies have investigated the prevalence of ILD in patients with psoriatic arthritis (PsA). Methotrexate (MTX) is frequently
Autor:
Dan Nordström, Johan Askling, Lene Dreyer, T. Schjødt Jørgensen, Merete Lund Hetland, D. Di Giuseppe, Heikki Relas, Bjorn Gudbjornsson, Bente Glintborg, Ulf Lindström, S. Aarrestad Provan, Brigitte Michelsen, L. T. H. Jacobsson, Kalle Aaltonen, Arni Jon Geirsson
Publikováno v:
Annals of the Rheumatic Diseases. 80:82-83
Background:In clinical practice, some patients with axial spondyloarthritis (axSpA) fail several consecutive biological treatments (bDMARDs). How this group of ”refractory” patients should best be defined, how common they are, and what their char